Physician profile
John Raff
NPI 1194768994
$3,083.44
in general payments reported to CMS, 2019-2025
11 companies · $223 in 2025
The $223 reported for 2025 was less than what a typical Orthopaedic Surgery provider received nationally (typical 2025 total: $569).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $361 · 2020: $118 · 2021: $67.81 · 2022: $135 · 2023: $2,043 · 2024: $135 · 2025: $223.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $1,706 · Food and Beverage: $695.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $1,706.00 |
| Food and Beverage | $695.19 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Stryker Corporation | $2,031.00 | 2019-2025 | Pro, Mako |
| Illuminoss Medical, INC. | $556.59 | 2021-2024 | Photodynamic Bone Stabilization Procedure Pack |
| Depuy Synthes Sales INC. | $170.36 | 2019-2020 | |
| Smith+Nephew, INC. | $73.79 | 2019 | |
| Orthofix Medical, INC. | $73.46 | 2019 | |
| Heron Therapeutics, INC. | $53.00 | 2023 | Zynrelef |
| Polynovo North America LLC | $48.24 | 2025 | Novosorb Btm |
| Davol INC. | $40.00 | 2023 | |
| Amgen INC. | $13.44 | 2024 | Evenity, Prolia |
| Si-Bone, INC. | $12.05 | 2021 | |
| Sanofi-Aventis U.S. LLC | $11.51 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw John Raff listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.